Page last updated: 2024-08-17

nad and ADPKD

nad has been researched along with ADPKD in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abu Aboud, O; Baloglu, E; Chen, X; Chmiel, KJ; Dionne, LK; Hwang, VJ; Li, X; Mahjoub, MR; Senapedis, W; Shim, K; Trott, J; Weiss, RH; Zhou, X	1

Other Studies

1 other study(ies) available for nad and ADPKD

Article	Year
Anticystogenic activity of a small molecule PAK4 inhibitor may be a novel treatment for autosomal dominant polycystic kidney disease. Kidney international, 2017, Volume: 92, Issue:4 Topics: Acrylamides; Aminopyridines; Animals; Apoptosis; beta Catenin; Cell Proliferation; Cytokines; Disease Models, Animal; Drug Evaluation, Preclinical; Epithelial Cells; Female; Humans; Kidney; Male; Mice; Mice, Transgenic; NAD; Nicotinamide Phosphoribosyltransferase; Organ Culture Techniques; p21-Activated Kinases; Phosphorylation; Polycystic Kidney, Autosomal Dominant; Receptors, Cell Surface; Signal Transduction; TRPP Cation Channels	2017

Article

Year

Anticystogenic activity of a small molecule PAK4 inhibitor may be a novel treatment for autosomal dominant polycystic kidney disease.

Kidney international, 2017, Volume: 92, Issue:4

Topics: Acrylamides; Aminopyridines; Animals; Apoptosis; beta Catenin; Cell Proliferation; Cytokines; Disease Models, Animal; Drug Evaluation, Preclinical; Epithelial Cells; Female; Humans; Kidney; Male; Mice; Mice, Transgenic; NAD; Nicotinamide Phosphoribosyltransferase; Organ Culture Techniques; p21-Activated Kinases; Phosphorylation; Polycystic Kidney, Autosomal Dominant; Receptors, Cell Surface; Signal Transduction; TRPP Cation Channels

2017